Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Measles | 10 | 2021 | 181 | 4.280 |
Why?
|
Immunization Programs | 10 | 2021 | 267 | 3.190 |
Why?
|
Cost-Benefit Analysis | 43 | 2023 | 5491 | 3.030 |
Why?
|
Measles Vaccine | 8 | 2021 | 79 | 2.920 |
Why?
|
Health Expenditures | 16 | 2021 | 2361 | 2.390 |
Why?
|
Developing Countries | 24 | 2021 | 2867 | 2.310 |
Why?
|
Taxes | 5 | 2020 | 221 | 2.060 |
Why?
|
Immunization | 5 | 2020 | 1217 | 1.790 |
Why?
|
Ethiopia | 15 | 2021 | 460 | 1.540 |
Why?
|
Catastrophic Illness | 3 | 2021 | 60 | 1.490 |
Why?
|
Child Mortality | 5 | 2020 | 199 | 1.490 |
Why?
|
Health Policy | 9 | 2021 | 2682 | 1.460 |
Why?
|
Rotavirus Infections | 4 | 2018 | 84 | 1.410 |
Why?
|
Poverty | 18 | 2021 | 2692 | 1.360 |
Why?
|
Vaccination | 11 | 2021 | 3370 | 1.270 |
Why?
|
Rotavirus Vaccines | 4 | 2018 | 62 | 1.190 |
Why?
|
Financing, Government | 6 | 2016 | 472 | 1.110 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2020 | 940 | 1.030 |
Why?
|
Delivery of Health Care | 16 | 2021 | 5332 | 1.030 |
Why?
|
Diarrhea | 7 | 2018 | 1317 | 1.000 |
Why?
|
Mass Vaccination | 3 | 2016 | 109 | 0.970 |
Why?
|
Maternal Mortality | 4 | 2016 | 301 | 0.960 |
Why?
|
Health Priorities | 3 | 2021 | 375 | 0.950 |
Why?
|
Child Health Services | 4 | 2016 | 644 | 0.950 |
Why?
|
Tuberculosis | 5 | 2019 | 2015 | 0.930 |
Why?
|
Insecticide-Treated Bednets | 4 | 2020 | 67 | 0.900 |
Why?
|
Public Policy | 6 | 2023 | 557 | 0.880 |
Why?
|
Health Care Costs | 9 | 2017 | 3238 | 0.860 |
Why?
|
Public Health | 5 | 2020 | 2669 | 0.770 |
Why?
|
Communicable Disease Control | 4 | 2021 | 846 | 0.760 |
Why?
|
Management Information Systems | 1 | 2021 | 49 | 0.760 |
Why?
|
HIV Infections | 12 | 2020 | 17337 | 0.740 |
Why?
|
Anthelmintics | 2 | 2018 | 83 | 0.710 |
Why?
|
Child Development | 3 | 2022 | 2300 | 0.690 |
Why?
|
Health Status Disparities | 3 | 2020 | 1846 | 0.680 |
Why?
|
Models, Theoretical | 9 | 2021 | 3567 | 0.680 |
Why?
|
Health Planning | 1 | 2021 | 230 | 0.660 |
Why?
|
Elephantiasis, Filarial | 1 | 2018 | 30 | 0.630 |
Why?
|
India | 9 | 2020 | 2286 | 0.630 |
Why?
|
Health Facilities | 2 | 2021 | 578 | 0.620 |
Why?
|
Mortality | 5 | 2021 | 2899 | 0.620 |
Why?
|
Schistosomiasis | 1 | 2018 | 65 | 0.620 |
Why?
|
Demography | 3 | 2020 | 1643 | 0.610 |
Why?
|
Quality-Adjusted Life Years | 8 | 2021 | 1722 | 0.600 |
Why?
|
Health Care Rationing | 1 | 2021 | 436 | 0.580 |
Why?
|
Communicable Diseases | 3 | 2021 | 871 | 0.580 |
Why?
|
Schools | 2 | 2023 | 1483 | 0.580 |
Why?
|
Malaria | 6 | 2020 | 1226 | 0.540 |
Why?
|
Commerce | 2 | 2020 | 608 | 0.540 |
Why?
|
Income | 9 | 2021 | 1870 | 0.540 |
Why?
|
South Africa | 8 | 2020 | 1836 | 0.540 |
Why?
|
Educational Status | 2 | 2023 | 2509 | 0.530 |
Why?
|
Child, Preschool | 24 | 2022 | 42188 | 0.530 |
Why?
|
Conservation of Natural Resources | 2 | 2017 | 208 | 0.510 |
Why?
|
Motorcycles | 1 | 2016 | 42 | 0.510 |
Why?
|
Growth Disorders | 1 | 2020 | 634 | 0.500 |
Why?
|
Public-Private Sector Partnerships | 1 | 2016 | 123 | 0.500 |
Why?
|
Workplace | 2 | 2021 | 863 | 0.500 |
Why?
|
Humans | 100 | 2024 | 760617 | 0.480 |
Why?
|
Head Protective Devices | 1 | 2016 | 118 | 0.470 |
Why?
|
Rubella | 1 | 2014 | 55 | 0.470 |
Why?
|
Health Status Indicators | 1 | 2020 | 969 | 0.470 |
Why?
|
Health Services Accessibility | 10 | 2021 | 5430 | 0.470 |
Why?
|
Specialties, Surgical | 3 | 2015 | 389 | 0.460 |
Why?
|
Biomedical Technology | 1 | 2016 | 210 | 0.460 |
Why?
|
Water Supply | 1 | 2015 | 204 | 0.450 |
Why?
|
Students | 1 | 2023 | 1733 | 0.440 |
Why?
|
Accidents, Traffic | 2 | 2016 | 816 | 0.440 |
Why?
|
Health Surveys | 4 | 2020 | 4037 | 0.430 |
Why?
|
Vaccines | 2 | 2018 | 838 | 0.410 |
Why?
|
Infant | 18 | 2020 | 36152 | 0.400 |
Why?
|
Circumcision, Male | 1 | 2013 | 148 | 0.390 |
Why?
|
Pneumococcal Vaccines | 1 | 2015 | 397 | 0.390 |
Why?
|
Program Evaluation | 1 | 2020 | 2486 | 0.390 |
Why?
|
Fertility | 1 | 2016 | 769 | 0.390 |
Why?
|
Wounds and Injuries | 1 | 2024 | 2491 | 0.390 |
Why?
|
Infant Mortality | 2 | 2014 | 751 | 0.380 |
Why?
|
Craniocerebral Trauma | 1 | 2016 | 490 | 0.370 |
Why?
|
Heterosexuality | 1 | 2013 | 309 | 0.370 |
Why?
|
Chemoprevention | 1 | 2013 | 325 | 0.370 |
Why?
|
Socioeconomic Factors | 7 | 2020 | 7798 | 0.370 |
Why?
|
Health Resources | 2 | 2016 | 933 | 0.370 |
Why?
|
Pneumococcal Infections | 1 | 2015 | 501 | 0.370 |
Why?
|
National Health Programs | 1 | 2014 | 440 | 0.350 |
Why?
|
Africa South of the Sahara | 4 | 2020 | 745 | 0.340 |
Why?
|
Surgical Procedures, Operative | 5 | 2015 | 1924 | 0.330 |
Why?
|
China | 5 | 2020 | 2374 | 0.330 |
Why?
|
Anti-Infective Agents | 2 | 2020 | 983 | 0.320 |
Why?
|
Preventive Health Services | 2 | 2017 | 566 | 0.300 |
Why?
|
Kenya | 4 | 2020 | 757 | 0.300 |
Why?
|
Child | 20 | 2023 | 80079 | 0.300 |
Why?
|
Anti-Infective Agents, Local | 1 | 2010 | 247 | 0.290 |
Why?
|
Maternal Health Services | 3 | 2019 | 460 | 0.290 |
Why?
|
Mass Screening | 2 | 2020 | 5424 | 0.290 |
Why?
|
Smoking Cessation | 2 | 2018 | 2056 | 0.280 |
Why?
|
Prevalence | 6 | 2020 | 15689 | 0.280 |
Why?
|
Anti-HIV Agents | 2 | 2013 | 4524 | 0.280 |
Why?
|
Female | 39 | 2024 | 392148 | 0.280 |
Why?
|
Vietnam | 2 | 2019 | 406 | 0.270 |
Why?
|
Cause of Death | 3 | 2024 | 3683 | 0.270 |
Why?
|
Medical Oncology | 1 | 2018 | 2317 | 0.270 |
Why?
|
Pneumonia | 1 | 2018 | 2143 | 0.270 |
Why?
|
Primary Prevention | 2 | 2013 | 1185 | 0.270 |
Why?
|
Nigeria | 2 | 2020 | 771 | 0.260 |
Why?
|
Male | 33 | 2024 | 360358 | 0.260 |
Why?
|
Namibia | 3 | 2020 | 28 | 0.260 |
Why?
|
Government Programs | 2 | 2018 | 278 | 0.260 |
Why?
|
General Surgery | 1 | 2017 | 1692 | 0.260 |
Why?
|
Helminthiasis | 2 | 2018 | 81 | 0.250 |
Why?
|
HIV | 1 | 2012 | 1579 | 0.250 |
Why?
|
Antitubercular Agents | 1 | 2014 | 1374 | 0.250 |
Why?
|
Family Characteristics | 2 | 2021 | 992 | 0.240 |
Why?
|
Vagina | 1 | 2010 | 841 | 0.240 |
Why?
|
Financing, Personal | 3 | 2016 | 308 | 0.240 |
Why?
|
Economic Development | 2 | 2015 | 69 | 0.240 |
Why?
|
Sexually Transmitted Diseases | 1 | 2010 | 661 | 0.240 |
Why?
|
Models, Statistical | 3 | 2020 | 5073 | 0.240 |
Why?
|
Research Report | 1 | 2017 | 367 | 0.230 |
Why?
|
Health Services Needs and Demand | 4 | 2020 | 1400 | 0.230 |
Why?
|
Models, Econometric | 2 | 2015 | 215 | 0.230 |
Why?
|
Models, Economic | 3 | 2020 | 714 | 0.230 |
Why?
|
Infant, Newborn | 11 | 2021 | 26180 | 0.220 |
Why?
|
Poliovirus Vaccines | 2 | 2013 | 13 | 0.220 |
Why?
|
Preventive Medicine | 1 | 2015 | 245 | 0.210 |
Why?
|
Adolescent | 16 | 2020 | 88234 | 0.200 |
Why?
|
Respiratory Tract Diseases | 1 | 2017 | 750 | 0.200 |
Why?
|
Cost of Illness | 4 | 2015 | 1935 | 0.190 |
Why?
|
Goals | 3 | 2016 | 708 | 0.190 |
Why?
|
Cote d'Ivoire | 1 | 2020 | 64 | 0.190 |
Why?
|
Mali | 1 | 2020 | 50 | 0.180 |
Why?
|
Ecuador | 1 | 2020 | 62 | 0.180 |
Why?
|
Patient Acceptance of Health Care | 3 | 2016 | 3194 | 0.180 |
Why?
|
Administration, Intravaginal | 2 | 2010 | 149 | 0.180 |
Why?
|
Vitamin A | 2 | 2013 | 612 | 0.170 |
Why?
|
Chile | 1 | 2020 | 256 | 0.170 |
Why?
|
Malaysia | 2 | 2018 | 107 | 0.170 |
Why?
|
Life Expectancy | 2 | 2018 | 1239 | 0.170 |
Why?
|
Adult | 21 | 2020 | 220969 | 0.170 |
Why?
|
Ghana | 1 | 2020 | 315 | 0.170 |
Why?
|
Young Adult | 11 | 2020 | 59179 | 0.160 |
Why?
|
Bicycling | 1 | 2020 | 177 | 0.160 |
Why?
|
Madagascar | 1 | 2018 | 109 | 0.160 |
Why?
|
Masks | 1 | 2021 | 208 | 0.160 |
Why?
|
Altruism | 1 | 2020 | 208 | 0.160 |
Why?
|
Tropical Medicine | 1 | 2018 | 51 | 0.150 |
Why?
|
Malaria Vaccines | 1 | 2020 | 163 | 0.150 |
Why?
|
Insecticides | 1 | 2020 | 191 | 0.150 |
Why?
|
Mexico | 1 | 2020 | 756 | 0.150 |
Why?
|
Soil | 1 | 2018 | 115 | 0.150 |
Why?
|
Transients and Migrants | 1 | 2020 | 165 | 0.150 |
Why?
|
Travel | 2 | 2021 | 796 | 0.150 |
Why?
|
Uganda | 2 | 2020 | 1332 | 0.150 |
Why?
|
Neoplasms | 3 | 2024 | 22131 | 0.150 |
Why?
|
Diphtheria-Tetanus Vaccine | 1 | 2017 | 3 | 0.150 |
Why?
|
CD4 Lymphocyte Count | 2 | 2015 | 2567 | 0.150 |
Why?
|
Artemisinins | 1 | 2020 | 218 | 0.150 |
Why?
|
Colombia | 1 | 2018 | 282 | 0.150 |
Why?
|
Geographic Information Systems | 1 | 2020 | 281 | 0.140 |
Why?
|
Botswana | 1 | 2020 | 1049 | 0.140 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 52 | 0.140 |
Why?
|
Middle Aged | 15 | 2020 | 220584 | 0.140 |
Why?
|
Risk Factors | 7 | 2021 | 74115 | 0.140 |
Why?
|
Population Growth | 1 | 2016 | 50 | 0.140 |
Why?
|
Perinatal Care | 1 | 2019 | 244 | 0.140 |
Why?
|
Brazil | 1 | 2020 | 1228 | 0.140 |
Why?
|
Policy Making | 2 | 2017 | 541 | 0.140 |
Why?
|
Consumer Product Safety | 1 | 2016 | 122 | 0.130 |
Why?
|
Lebanon | 1 | 2016 | 242 | 0.130 |
Why?
|
Aged | 12 | 2021 | 169042 | 0.130 |
Why?
|
Population Density | 1 | 2015 | 193 | 0.120 |
Why?
|
Costs and Cost Analysis | 2 | 2018 | 1663 | 0.120 |
Why?
|
Vitamins | 2 | 2013 | 1635 | 0.120 |
Why?
|
Primary Health Care | 3 | 2016 | 4668 | 0.120 |
Why?
|
Survival Analysis | 4 | 2019 | 10073 | 0.120 |
Why?
|
Needs Assessment | 1 | 2020 | 1139 | 0.110 |
Why?
|
Nutrition Disorders | 1 | 2014 | 204 | 0.110 |
Why?
|
Autopsy | 1 | 2017 | 1008 | 0.110 |
Why?
|
Regression Analysis | 2 | 2013 | 6338 | 0.110 |
Why?
|
Morals | 1 | 2016 | 289 | 0.110 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15498 | 0.110 |
Why?
|
Vitamin A Deficiency | 1 | 2013 | 88 | 0.110 |
Why?
|
Water Purification | 1 | 2013 | 60 | 0.110 |
Why?
|
Capacity Building | 1 | 2015 | 259 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2020 | 2700 | 0.100 |
Why?
|
Patient Compliance | 2 | 2013 | 2688 | 0.100 |
Why?
|
Age Factors | 2 | 2020 | 18381 | 0.100 |
Why?
|
Palliative Care | 1 | 2017 | 3592 | 0.100 |
Why?
|
Forecasting | 3 | 2016 | 2924 | 0.100 |
Why?
|
Health Education | 1 | 2018 | 1049 | 0.100 |
Why?
|
Sexual Behavior | 2 | 2013 | 2187 | 0.100 |
Why?
|
Lost to Follow-Up | 1 | 2012 | 123 | 0.100 |
Why?
|
Health Promotion | 2 | 2014 | 2206 | 0.100 |
Why?
|
Sodium, Dietary | 1 | 2015 | 425 | 0.090 |
Why?
|
Government Regulation | 1 | 2016 | 524 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10199 | 0.090 |
Why?
|
Emigrants and Immigrants | 1 | 2017 | 544 | 0.090 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 730 | 0.090 |
Why?
|
Checklist | 1 | 2017 | 827 | 0.090 |
Why?
|
World Health Organization | 1 | 2016 | 1321 | 0.090 |
Why?
|
Cesarean Section | 2 | 2016 | 1396 | 0.080 |
Why?
|
Developed Countries | 1 | 2012 | 450 | 0.080 |
Why?
|
Biophysics | 1 | 2010 | 379 | 0.080 |
Why?
|
Respiratory Tract Infections | 1 | 2016 | 1009 | 0.080 |
Why?
|
Papillomavirus Vaccines | 1 | 2015 | 496 | 0.080 |
Why?
|
Cost Savings | 2 | 2013 | 912 | 0.080 |
Why?
|
Condoms | 1 | 2010 | 330 | 0.080 |
Why?
|
Hypertension | 2 | 2020 | 8529 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7389 | 0.070 |
Why?
|
Linear Models | 2 | 2015 | 5866 | 0.070 |
Why?
|
Online Systems | 1 | 2017 | 182 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2643 | 0.070 |
Why?
|
California | 1 | 2010 | 1430 | 0.070 |
Why?
|
Incidence | 3 | 2020 | 21337 | 0.070 |
Why?
|
Ethics, Research | 1 | 2017 | 176 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2013 | 2423 | 0.070 |
Why?
|
Viral Load | 1 | 2015 | 3325 | 0.060 |
Why?
|
Disease Outbreaks | 1 | 2014 | 1748 | 0.060 |
Why?
|
HIV-1 | 2 | 2013 | 6858 | 0.060 |
Why?
|
Adolescent Development | 1 | 2017 | 281 | 0.060 |
Why?
|
Pregnancy | 3 | 2021 | 29868 | 0.060 |
Why?
|
Insurance, Health | 1 | 2016 | 2495 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3918 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5886 | 0.060 |
Why?
|
Pediatrics | 1 | 2018 | 3588 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2017 | 58894 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1611 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2020 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
Registries | 1 | 2018 | 8207 | 0.050 |
Why?
|
Drug Costs | 1 | 2010 | 1183 | 0.050 |
Why?
|
Health Status | 1 | 2015 | 4075 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5835 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2016 | 4321 | 0.050 |
Why?
|
Disease Progression | 2 | 2015 | 13495 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14591 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26049 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8645 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3351 | 0.040 |
Why?
|
Caribbean Region | 1 | 2019 | 192 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2020 | 80566 | 0.040 |
Why?
|
Angola | 1 | 2018 | 18 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4007 | 0.040 |
Why?
|
Latin America | 1 | 2019 | 407 | 0.040 |
Why?
|
Cities | 1 | 2020 | 546 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9050 | 0.040 |
Why?
|
Mosquito Control | 1 | 2018 | 106 | 0.040 |
Why?
|
Population Groups | 1 | 2018 | 207 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20074 | 0.030 |
Why?
|
Norway | 1 | 2018 | 499 | 0.030 |
Why?
|
Perinatal Mortality | 1 | 2016 | 101 | 0.030 |
Why?
|
Oceania | 1 | 2015 | 16 | 0.030 |
Why?
|
Americas | 1 | 2015 | 110 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3680 | 0.030 |
Why?
|
Urban Health Services | 1 | 2016 | 176 | 0.030 |
Why?
|
Rural Health | 1 | 2016 | 296 | 0.030 |
Why?
|
Technology Assessment, Biomedical | 1 | 2017 | 306 | 0.030 |
Why?
|
Rwanda | 1 | 2016 | 656 | 0.030 |
Why?
|
Rural Population | 2 | 2015 | 2276 | 0.030 |
Why?
|
United Nations | 1 | 2014 | 149 | 0.030 |
Why?
|
Asia | 1 | 2015 | 615 | 0.030 |
Why?
|
Biostatistics | 1 | 2015 | 163 | 0.030 |
Why?
|
Hospitalization | 1 | 2013 | 10704 | 0.030 |
Why?
|
Urban Health | 1 | 2016 | 532 | 0.030 |
Why?
|
Africa | 1 | 2015 | 710 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 544 | 0.030 |
Why?
|
Filtration | 1 | 2013 | 228 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20988 | 0.020 |
Why?
|
Rural Health Services | 1 | 2016 | 384 | 0.020 |
Why?
|
Tanzania | 1 | 2016 | 1390 | 0.020 |
Why?
|
Research Design | 1 | 2017 | 6174 | 0.020 |
Why?
|
Algorithms | 1 | 2010 | 14018 | 0.020 |
Why?
|
Cohort Studies | 1 | 2012 | 41457 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1000 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3413 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1335 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2013 | 64568 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1790 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2016 | 2090 | 0.020 |
Why?
|
Epidemics | 1 | 2011 | 512 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11116 | 0.010 |
Why?
|
Anesthesia | 1 | 2015 | 1591 | 0.010 |
Why?
|
Disabled Persons | 1 | 2014 | 1226 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2013 | 1782 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2011 | 1894 | 0.010 |
Why?
|
United States | 1 | 2010 | 72272 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 3196 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14648 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 39913 | 0.010 |
Why?
|
Concepts
(289)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_